XML 27 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net loss $ (10,055) $ (41,456) $ (27,009)
Adjustments to reconcile net loss to cash provided by operating activities:      
Depreciation and amortization 6,814 5,164 5,388
Reduction of operating lease right-of-use assets 547 614 666
Loss on impairment, receivables and sale or disposal of equipment 727 923 881
Stock-based compensation 33,537 41,212 52,332
Amortization of original issue discount and debt issuance costs 54 257 42
Deferred tax assets (42) (113) 26
Changes in assets and liabilities:      
Settlement assets, net (2,469) (6,398) (7,796)
Prepaid expenses (1,490) 3,176 (1,389)
Other current assets 2,341 (561) 2,875
Other assets (167) (5,130) (81)
Accounts payable (1,091) 228 (2,693)
Accrued expenses and other liabilities (404) 906 (1,537)
Operating lease liabilities 8 (200) (758)
Settlement liabilities (5,145) 108 12,202
Other liabilities 8 610 1,054
Net cash provided by operating activities 23,877 1,559 32,876
Cash flows from investing activities:      
Purchase of property and equipment 0 (1,384) (585)
Proceeds from sale or disposal of property and equipment 0 0 5
Software development costs (7,628) (5,910) (1,619)
Net cash used in investing activities (7,628) (7,294) (2,199)
Cash flows from financing activities:      
Principal payments of finance leases (129) (513) (793)
Principal payments of outstanding debt (22,671) (44,587) (595)
Repurchases of early exercises of common stock (35) (17) (25)
Proceeds from common stock purchased under Matching Plan 4,091 4,255 3,672
Proceeds from issuance of common stock on exercise of stock options 431 311 795
Payments for debt issuance costs (71) 0 0
Payments for employee taxes withheld from stock-based awards (2,179) (1,766) (5,336)
Repurchase and retirement of common stock (1,510) (3,000) (6,000)
Net cash used in financing activities (22,073) (45,317) (8,282)
Net (decrease) increase in cash and cash equivalents and restricted cash (5,824) (51,052) 22,395
Cash and cash equivalents and restricted cash, beginning of period 96,658 147,710 125,315
Cash and cash equivalents and restricted cash, end of period 90,834 96,658 147,710
Supplemental disclosure of cash flow information:      
Cash paid for interest 1,362 5,936 3,912
Cash paid for income taxes 5,072 3,785 975
Noncash investing and financing items:      
Stock-based compensation capitalized as software development costs 2,688 3,126 1,757
Purchases of property and equipment and capitalized software in accounts payable and accrued expenses 37 390 0
Right-of-use assets acquired through operating leases 0 6,402 0
Right-of-use assets acquired through finance leases 0 409 0
Cashless exercise of stock options 335 0 0
Reconciliation of cash and cash equivalents and restricted cash to the Consolidated Balance Sheets:      
Cash and cash equivalents 48,772 47,510 103,787
Restricted cash included in other current assets 19,980 27,742 19,542
Restricted cash included in settlement assets, net 22,082 21,406 24,381
Total cash and cash equivalents and restricted cash 90,834 96,658 147,710
Nonrelated Party      
Changes in assets and liabilities:      
Accounts receivable, net 704 2,219 (1,341)
Related party loan receivable 704 2,219 (1,341)
Related Party      
Changes in assets and liabilities:      
Accounts receivable, net 0 0 14
Related party loan receivable $ 0 $ 0 $ 14